Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis.
Mitchell L RamseyYevgeniya GokunLindsay A SobotkaMichael R WellnerKyle PorterStephen E KirkbySusan S LiGeorgios I PapachristouSomashekar G KrishnaPeter P StanichPhil A HartDarwin L ConwellLuis F LaraPublished in: The American journal of gastroenterology (2021)
CFTR modulator use is associated with a reduction in AP hospitalizations among patients with CF. These observational data support the prospective study of CFTR modulators to reduce AP hospitalizations among patients with CF.